{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:49:54Z","timestamp":1790675394912,"version":"4.1.0"},"reference-count":56,"publisher":"American Society for Microbiology","issue":"18","license":[{"start":{"date-parts":[[2001,9,15]],"date-time":"2001-09-15T00:00:00Z","timestamp":1000512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2001,9,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Carriers of certain human leukocyte antigen class I alleles show favorable prognosis of human immunodeficiency virus type 1 (HIV-1) infection, presumably due to effective CD8<jats:sup>+<\/jats:sup>cytotoxic T-lymphocyte responses, but close relationships between class I variants mediating such responses to natural and to vaccine HIV-1 antigen have not been established. During 6 to 30 months of administration and follow-up in trials of ALVAC-HIV recombinant canarypox vaccines, cells from 42% of 291 HIV-1-negative vaccinated subjects typed at class I loci responded to an HIV-1 protein in a lytic bulk CD8<jats:sup>+<\/jats:sup>cytotoxic T-lymphocyte assay. By 2 weeks after the second dose, higher proportions of vaccinees carrying one of two alleles consistently associated with slower progression of natural HIV-1 infection reacted at least once: B\u221727 carriers reacted to Gag (64%; odds ratio [OR] = 10.3,<jats:italic>P<\/jats:italic>= 0.001) and Env (36%; OR = 4.6,<jats:italic>P<\/jats:italic>= 0.04), and B\u221757 carriers reacted to Env (44%; OR = 6.6,<jats:italic>P<\/jats:italic>&lt; 0.05). By 2 weeks after the third or fourth dose, B\u221727 carriers had responded (two or more reactions) to Gag (33%; OR = 4.4,<jats:italic>P<\/jats:italic>&lt; 0.05) and B\u221757 carriers had responded to both Gag (39%; OR = 5.3,<jats:italic>P<\/jats:italic>= 0.013) and Env (39%; OR = 9.5,<jats:italic>P<\/jats:italic>= 0.002). Homozygosity at class I loci, although conferring an unfavorable prognosis following natural infection, showed no such disadvantage for vaccine response. Individual class I alleles have not previously demonstrated such clear and consistent relationship with both the clinical course of an infection and cellular immunity to a vaccine against the infectious agent. This proof of principle that class I an alleles modulate both processes has implications for development of HIV-1 and presumably other vaccines.<\/jats:p>","DOI":"10.1128\/jvi.75.18.8681-8689.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:58:35Z","timestamp":1027763915000},"page":"8681-8689","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":89,"title":["Polymorphisms in HLA Class I Genes Associated with both Favorable Prognosis of Human Immunodeficiency Virus (HIV) Type 1 Infection and Positive Cytotoxic T-Lymphocyte Responses to ALVAC-HIV Recombinant Canarypox Vaccines"],"prefix":"10.1128","volume":"75","author":[{"given":"Richard A.","family":"Kaslow","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Epidemiology and International Health, School of Public Health,1 and"},{"name":"<!--label omitted: 2-->Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 352942;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Rivers","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Epidemiology and International Health, School of Public Health,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Tang","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 352942;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Bender","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Epidemiology and International Health, School of Public Health,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Goepfert","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 352942;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaelle","family":"El Habib","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Aventis Pasteur, Marcy l'Etoile, France3; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Weinhold","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Duke University Medical Center, Durham, North Carolina 277104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Mulligan","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 352942;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the NIAID Aids Vaccine Evaluation Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/35030124"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.290.5491.486"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199818000-00009"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1999.tb01336.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/314556"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.1999.530421.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0297-205"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5408.1748"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1995.tb02408.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/515288"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199910010-00031"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/15224"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/314895"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.4.1396"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.071548198"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105313442203"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(99)00142-1"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00020-2"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0297-212"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.12.5679-5690.2000"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1996.12.1691"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199715000-00015"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00133-8"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.4049\/jimmunol.162.11.6942","article-title":"New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS","volume":"162","author":"Hendel H.","year":"1999","unstructured":"Hendel H. Caillat-Zucman S. Lebuanec H. Carrington M. O'Brien S. Andrieu J. M. Schachter F. Zagury D. Rappaport J. Winkler C. Nelson G. W. Zagury J. F. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS.J. Immunol. 162 1999 6942 6946","journal-title":"J. Immunol."},{"key":"e_1_3_2_26_2","first-page":"37","article-title":"HLA-B35 is associated with accelerated progression to AIDS","volume":"5","author":"Itescu S.","year":"1992","unstructured":"Itescu S. Mathur-Wagh U. Skovron M. L. Brancato L. J. Marmor M. Zeleniuch-Jacquotte A. Winchester R. HLA-B35 is associated with accelerated progression to AIDS.J. Acquir. Immune Defic. Syndr. 5 1992 37 45","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.6.991"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.10.7711-7718.1997"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0496-405"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90995-H"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.3.1602"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199601001-00009"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/314862"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.3.375"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(96)10081-0"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.4.1365"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.7.4650-4655.1994"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.2.495"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/315472"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.3.936"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","unstructured":"Marsh S. G. E. Parham P. Barber L. D. The HLA facts book. 2000 Academic Press San Diego Calif","DOI":"10.1016\/B978-012545025-6\/50148-9"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1997.13.211"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/89.3.177"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.11.1921"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.050567397"},{"key":"e_1_3_2_46_2","first-page":"S105","article-title":"Human trials of HIV-1 vaccines","volume":"13","author":"Mulligan M. J.","year":"1999","unstructured":"Mulligan M. J. Webber J. Human trials of HIV-1 vaccines AIDS. 13 (Suppl. A) 1999 S105 S112","journal-title":"AIDS."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.18.9802"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118133"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.9.5838-5842.1995"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(98)00086-X"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(98)00179-5"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4314"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.11.6015"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.6.2502-2509.2000"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922299311277"},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4049\/jimmunol.161.3.1406","article-title":"Sequence-based typing provides a new look at HLA-C diversity","volume":"161","author":"Turner S.","year":"1998","unstructured":"Turner S. Ellexson M. E. Hickman H. Sidebottom D. A. Fernandez-Vina M. Confer D. L. Hildebrand W. H. Sequence-based typing provides a new look at HLA-C diversity.J. Immunol. 161 1998 1406 1413","journal-title":"J. Immunol."},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200002180-00003"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.75.18.8681-8689.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.75.18.8681-8689.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:06:47Z","timestamp":1682262407000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.75.18.8681-8689.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,15]]},"references-count":56,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2001,9,15]]}},"alternative-id":["10.1128\/JVI.75.18.8681-8689.2001"],"URL":"https:\/\/doi.org\/10.1128\/jvi.75.18.8681-8689.2001","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9,15]]},"assertion":[{"value":"2001-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-06-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-09-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}